EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Induct AS: AstraZeneca Initiates Commercial Discussions Earlier Than Planned
Principal Street Partners LLC Lowers Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Zacks Research Lowers Earnings Estimates for AstraZeneca
UK court clears the way for Amgen and Samsung to launch biosimilars
Astrazeneca's AZD-6793 arises as a promising therapeutic for COPD | BioWorld
Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27
Other news to note for May 21, 2025 | BioWorld
Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer
AstraZeneca's Airsupra asthma treatment shows breakthrough results in trial
AstraZeneca Acquires EsoBiotec To Advance Instant IV-Delivered Cell Therapy For Cancer Treatment
Compugen Ltd. (NASDAQ:CGEN) Q1 2025 Earnings Call Transcript
Texas Bank & Trust Co Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (AZN) Trial: Airsupra Cuts Severe Asthma Risk by 47%
Tezepelumab Cuts Oral Corticosteroid Use in Severe Asthma
Cancer treatment paradigms in the precision medicine era
Soleus Capital Management L.P. Purchases Shares of 409,000 AstraZeneca PLC (NASDAQ:AZN)
Rafferty Asset Management LLC Buys 46,918 Shares of AstraZeneca PLC (NASDAQ:AZN)
Deutsche Bank AG Buys 6,039 Shares of AstraZeneca PLC (NASDAQ:AZN)
Combo Inhaler Better for Mild Asthma
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Strategic Wealth Partners Ltd.
Nomura Holdings Inc. Sells 127,159 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Pathstone Holdings LLC
Wuxi steps up biomedical excellence - Chinadaily.com.cn
The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study
Shandong takes action to serve development of MNCs in the province
Rep. Bruce Westerman Sells AstraZeneca PLC (NASDAQ:AZN) Shares
Aptamer announces new data at ASGCT
APOBEC3 mutagenesis drives therapy resistance in breast cancer
How AstraZeneca Has Created its First Sustainable Inhaler
Enhertu Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2024, 2024-2029, 2034F
Pathstone Holdings LLC Acquires 22,995 Shares of AstraZeneca PLC (NASDAQ:AZN)
Lazard Asset Management LLC Trims Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Janus Henderson Group PLC Purchases 374,705 Shares of AstraZeneca PLC (NASDAQ:AZN)
Automation of flow cytometry data analysis with elastic image registration
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Fiduciary Trust Co Raises Position in AstraZeneca PLC (NASDAQ:AZN)
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification
Investment Opportunities in Singapore's Biopharma Sector
Is AstraZeneca (AZN) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?
This inhaler not just helps with COPD but is also climate-friendly
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial
Cellectis Reports Financial Results for the First Quarter 2025 | Taiwan News | May. 13, 2025 04:30
Potential Impact on AstraZeneca (AZN) from U.S. Pharma Pricing Executive Order | AZN Stock News
Integral Health Asset Management LLC Acquires New Stake in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca (AZN) Gains UK Approval for Eco-Friendly Inhaler Propellant | AZN Stock News
Why did the AstraZeneca share price just fall, and what should we do?
AstraZeneca PLC (NASDAQ:AZN) Position Boosted by Ethic Inc.
AstraZeneca Loses Spot as UK's Most Valuable Company to HSBC
EP Wealth Advisors LLC Purchases 7,802 Shares of AstraZeneca PLC (NASDAQ:AZN)
55,922 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Cubist Systematic Strategies LLC
Cary Street Partners Financial LLC Takes Position in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca (AZN) Faces Market Uncertainty Amid Drug Pricing Changes | AZN Stock News
Augmented reality microscopy to bridge trust between AI and pathologists
Ellevest Inc. Sells 5,080 Shares of AstraZeneca PLC (NASDAQ:AZN)
BNP Paribas Financial Markets Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)
"Absci" Tag - The Columbian
Crestline Management LP Sells 23,934 Shares of AstraZeneca PLC (NASDAQ:AZN)
Aptus Capital Advisors LLC Boosts Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment
AstraZeneca's Imfinzi Shows Promising Results in Bladder Cancer Trial (AZN)
Bridgefront Capital LLC Makes New $213,000 Investment in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca (AZN) Trial Reveals Promising Results for Bladder Cancer Treatment | AZN Stock News
IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial | Morningstar
Baird Financial Group Inc. Boosts Position in AstraZeneca PLC (NASDAQ:AZN)
US court shuts down AstraZeneca's challenge to Medicare drug price plan
AZN: Imfinzi Combination Improves Disease-Free Survival In Phase III High-Risk Bladder Cancer Trial
Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort
AstraZeneca breaks ground on new small molecule drug factory in Wuxi - Chinadaily.com.cn
World Asthma Day commemorated with call for access to treatment - BusinessGhana
AstraZeneca (AZN) Sees Increased Bullish Option Activity | AZN Stock News
AstraZeneca PLC (AZN) Shares Down 3.48% on May 8
Tempus AI Stock: Time to Double Down or Cut and Run? | Investing.com
AstraZeneca Loses Bid to Revive Drug Price Suit at Third Circuit
AstraZeneca cancer blockbuster Enhertu secures CDSCO nod for additional indication
Covenant Partners LLC Has $677,000 Position in AstraZeneca PLC (NASDAQ:AZN)
Aptus Capital Advisors LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)
Benjamin Edwards Inc. Has $3.67 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)
Next-Generation Complement Therapeutics Market Set to Reach $12.9 Billion by 2034
Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems
Zanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trial
RANO criteria for response assessment of brain metastases based on amino acid PET imaging
Tempus AI, Inc. (NASDAQ:TEM) Q1 2025 Earnings Call Transcript
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2025 Earnings Call Transcript
AstraZeneca (AZN) Sees Positive Results in DESTINY-Breast11 Trial | AZN Stock News
Bank of America Corp DE Grows Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Alteri Wealth LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)
ENHERTU® Followed by THP Before Surgery Showed Statistically Sig
Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Arcus Biosciences Inc (RCUS) Q1 2025 Earnings Call Highlights: Strategic Focus and Financial ...
Arcus Biosciences Q1 2025 Earnings: EPS Misses at -$1.14, Revenue Falls Short at $28 Million
AstraZeneca opens $300 million cell therapy manufacturing facility in Maryland | Fox Business
AstraZeneca (AZN): Impact of FDA's New Inspection Strategy on Foreign Facilities | AZN Stock News
AstraZeneca's (AZN) Calquence Gains EU Approval for Mantle Cell Lymphoma Treatment | AZN Stock News
AstraZeneca News
Latest news
Show more
Morning Note: Japan's Core Inflation Spikes; UK Retail Surges; Canada Sales Slow
Morning Note: Nvidia Slams China Chip Ban; Bitcoin Climbs on Trade Peace;
Morning Note: UK Inflation Surprises Higher; Mideast Tensions Fuel Oil, Gold
